INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NuScale Power Corporation

UBS downgraded NuScale Power to Sell from Neutral and cut its price target to $6 from $10, citing lost SMR first-mover advantages, limited firm customer commitments, and an estimated $700 million of negative free cash flow in 2026-2028. NuScale shares fell $1.60, or 15.67%, to $8.61 on September 11. Pomerantz LLP is investigating potential securities-fraud or other unlawful-business-practice claims involving NuScale and certain officers or directors, adding legal risk following the downgrade.

Analysis

The actionable issue is not litigation risk; it is financing risk. A multi-year development cycle combined with projected cash burn creates a recurring equity-issuance overhang, so downside can persist even after the initial analyst-driven repricing. Unless binding, financeable customer contracts emerge, the market is likely to value SMR on cash runway and dilution probability rather than on a terminal-value narrative.

Competitive pressure favors nuclear incumbents and suppliers with funded order books, manufacturing capacity, and balance-sheet support. BWXT and GEV are better positioned to monetize rising nuclear procurement without requiring investors to underwrite a single-company commercialization timeline; a shift in utility procurement toward proven delivery capability could widen their valuation premium over pre-revenue reactor developers over the next 6-18 months.

The near-term bear case is vulnerable to one catalyst: a definitive project financing package, utility offtake agreement, or government-backed milestone that converts prospective demand into contracted backlog. Absent that, quarterly cash-burn disclosures and any revision to project timing should be the principal 1-3 month catalysts. The lawsuit announcement itself is routine plaintiff-bar activity and should not be treated as an incremental fundamental short signal unless it produces evidence contradicting prior disclosures.

Consensus may be underestimating the asymmetry of policy headlines: SMR has a high-short-interest-style narrative profile, where an announced federal support mechanism or named customer can drive sharp rallies despite weak economics. That argues for defined-risk bearish structures rather than an unhedged short after a large one-day decline.

Key Decisions for Investors

• Maintain a bearish SMR bias for the next 1-3 months, but wait for a failed rebound or a financing-related disclosure rather than chase the post-downgrade gap. A tactical short toward the $6 analyst valuation framework offers roughly 30% downside from $8.61; cover if shares reclaim $10 on independently verified contracted backlog or non-dilutive project financing.
• Prefer a 6-12 month pair: long BWXT / short SMR in dollar-neutral sizing. The trade isolates the expected repricing from speculative reactor development toward nuclear execution and component capacity; exit if SMR secures binding customer commitments that materially cover its projected funding needs.
• Do not initiate SMR puts without confirming option liquidity, implied volatility, and borrow availability. If puts are liquid, favor put spreads rather than outright puts because policy or customer-announcement headlines can generate abrupt upside gaps.
• Set alerts for quarterly operating cash flow, share-count growth, RoPower funding milestones, and TVA-related commitments. A lower-than-expected cash burn or a credible financing package would falsify the dilution thesis; continued burn without firm commitments strengthens it.